Literature DB >> 33298513

Cognitive Impairment in Older Adults and Therapeutic Strategies.

Thomas J Montine1, Syed A Bukhari2, Lon R White2.   

Abstract

Cognitive impairment and its severe form dementia are increasingly prevalent in older adults and loom as a public health disaster unless effective interventions are developed. Cognitive impairment is a convergent trait caused by damage from an idiosyncratic mix of four prevalent diseases (Alzheimer disease; vascular brain injury; Lewy body diseases, such as Parkinson disease and dementia with Lewy bodies; and limbic-predominant age-related transactive response DNA-binding protein 43 encephalopathy) that is counterbalanced by individually varying resilience, which is comprised of reserve and compensation. Brain regional damage from each of these four prevalent diseases is generated by the net effect of injury and (mal)adaptive response and is accompanied by characteristic lesions. Existing therapeutics enhance resilience, whereas most agents under development target mechanisms of damage with only suppression of vascular brain injury yet to show therapeutic promise. We hope to anticipate future tailored interventions that target mechanisms of damage and thereby avert the oncoming surge of cognitive impairment and dementia in older adults. SIGNIFICANCE STATEMENT: Brain regional damage is generated by the net effect of injury and (mal)adaptive response. The extent to which signs and symptoms of such damage occur is influenced by an underlying resilience comprising reserve and compensation. Finding tailored interventions that target specific mechanisms of damage likely yields the most effective therapies.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Year:  2021        PMID: 33298513      PMCID: PMC7736830          DOI: 10.1124/pharmrev.120.000031

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  79 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study.

Authors:  Sverre E Kjeldsen; Krzysztof Narkiewicz; Michel Burnier; Suzanne Oparil
Journal:  Blood Press       Date:  2018-10       Impact factor: 2.835

3.  The aftermath of boxing.

Authors:  J A Corsellis; C J Bruton; D Freeman-Browne
Journal:  Psychol Med       Date:  1973-08       Impact factor: 7.723

4.  Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele.

Authors:  T Arendt; C Schindler; M K Brückner; K Eschrich; V Bigl; D Zedlick; L Marcova
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

5.  Primum non nocere: a call for balance when reporting on CTE.

Authors:  William Stewart; Kieren Allinson; Safa Al-Sarraj; Corbin Bachmeier; Karen Barlow; Antonio Belli; Mark P Burns; Alan Carson; Fiona Crawford; Kristen Dams-O'Connor; Ramon Diaz-Arrastia; C Edward Dixon; Brian L Edlow; Scott Ferguson; Bruce Fischl; Rebecca D Folkerth; Steve Gentleman; Christopher C Giza; M Sean Grady; Adel Helmy; Mark Herceg; Janice L Holton; David Howell; Peter J Hutchinson; Diego Iacono; Juan E Iglesias; Milos D Ikonomovic; Victoria E Johnson; C Dirk Keene; Julia K Kofler; Vassilis E Koliatsos; Edward B Lee; Harvey Levin; Jonathan Lifshitz; Helen Ling; David J Loane; Seth Love; Andrew Ir Maas; Niklas Marklund; Christina L Master; Damien M McElvenny; David F Meaney; David K Menon; Thomas J Montine; Benoit Mouzon; Elliott J Mufson; Joseph O Ojo; Mayumi Prins; Tamas Revesz; Craig W Ritchie; Colin Smith; Richard Sylvester; Cheuk Y Tang; John Q Trojanowski; Kathryn Urankar; Robert Vink; Cheryl Wellington; Elisabeth A Wilde; Lindsay Wilson; Keith Yeates; Douglas H Smith
Journal:  Lancet Neurol       Date:  2019-02-12       Impact factor: 44.182

6.  Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.

Authors:  Christopher M Clark; Michael J Pontecorvo; Thomas G Beach; Barry J Bedell; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Eric M Reiman; Marwan N Sabbagh; Carl H Sadowsky; Julie A Schneider; Anupa Arora; Alan P Carpenter; Matthew L Flitter; Abhinay D Joshi; Michael J Krautkramer; Ming Lu; Mark A Mintun; Daniel M Skovronsky
Journal:  Lancet Neurol       Date:  2012-06-28       Impact factor: 44.182

7.  Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies.

Authors:  Lon R White; Steven D Edland; Laura S Hemmy; Kathleen S Montine; Chris Zarow; Joshua A Sonnen; Jane H Uyehara-Lock; Rebecca P Gelber; G Webster Ross; Helen Petrovitch; Kamal H Masaki; Kelvin O Lim; Lenore J Launer; Thomas J Montine
Journal:  Neurology       Date:  2016-02-17       Impact factor: 9.910

Review 8.  Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

Authors:  Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka
Journal:  Neurology       Date:  2017-06-07       Impact factor: 9.910

9.  Resistance to Alzheimer Disease Neuropathologic Changes and Apparent Cognitive Resilience in the Nun and Honolulu-Asia Aging Studies.

Authors:  Caitlin S Latimer; C Dirk Keene; Margaret E Flanagan; Laura S Hemmy; Kelvin O Lim; Lon R White; Kathleen S Montine; Thomas J Montine
Journal:  J Neuropathol Exp Neurol       Date:  2017-06-01       Impact factor: 3.148

Review 10.  Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders.

Authors:  Robert W Mahley
Journal:  J Mol Med (Berl)       Date:  2016-06-09       Impact factor: 4.599

View more
  7 in total

1.  Age and attentional focus instructions effects on postural and supra-postural tasks among older adults with mild cognitive impairments.

Authors:  Mandana Sangari; Parvaneh Shamsipour Dehkordi; Amir Shams
Journal:  Neurol Sci       Date:  2022-08-29       Impact factor: 3.830

2.  Classification of Cognitive Impairment and Healthy Controls Based on Transcranial Magnetic Stimulation Evoked Potentials.

Authors:  Jiahao Zhang; Haifeng Lu; Lin Zhu; Huixia Ren; Ge Dang; Xiaolin Su; Xiaoyong Lan; Xin Jiang; Xu Zhang; Jiansong Feng; Xue Shi; Taihong Wang; Xiping Hu; Yi Guo
Journal:  Front Aging Neurosci       Date:  2021-12-24       Impact factor: 5.750

3.  Single-synapse analyses of Alzheimer's disease implicate pathologic tau, DJ1, CD47, and ApoE.

Authors:  Thanaphong Phongpreecha; Chandresh R Gajera; Candace C Liu; Kausalia Vijayaragavan; Alan L Chang; Martin Becker; Ramin Fallahzadeh; Rosemary Fernandez; Nadia Postupna; Emily Sherfield; Dmitry Tebaykin; Caitlin Latimer; Carol A Shively; Thomas C Register; Suzanne Craft; Kathleen S Montine; Edward J Fox; Kathleen L Poston; C Dirk Keene; Michael Angelo; Sean C Bendall; Nima Aghaeepour; Thomas J Montine
Journal:  Sci Adv       Date:  2021-12-15       Impact factor: 14.136

4.  Capsaicin Ameliorates the Loosening of Mitochondria-Associated Endoplasmic Reticulum Membranes and Improves Cognitive Function in Rats With Chronic Cerebral Hypoperfusion.

Authors:  Mengqi Ouyang; Qi Zhang; Jiahui Shu; Zhiqiang Wang; Jin Fan; Ke Yu; Lei Lei; Yuxia Li; Qingsong Wang
Journal:  Front Cell Neurosci       Date:  2022-03-17       Impact factor: 5.505

5.  CT-Detected MTA Score Related to Disability and Behavior in Older People with Cognitive Impairment.

Authors:  Michele Lauriola; Grazia D'Onofrio; Annamaria la Torre; Filomena Ciccone; Carmela Germano; Leandro Cascavilla; Antonio Greco
Journal:  Biomedicines       Date:  2022-06-10

6.  Cognitive Impairment and Its Associated Factors in Older Adults Living in High and Low Altitude Areas: A Comparative Study.

Authors:  Shou Liu; Fei Wang; Cheng Zhang; Qinge Zhang; Zhan-Cui Dang; Chee H Ng; Yu-Tao Xiang
Journal:  Front Psychiatry       Date:  2022-06-23       Impact factor: 5.435

Review 7.  The Role of the NRF2 Pathway in Maintaining and Improving Cognitive Function.

Authors:  Nora E Gray; Marcelo Farina; Paolo Tucci; Luciano Saso
Journal:  Biomedicines       Date:  2022-08-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.